For instance, the inverse agonists of RORα and RORγ, SR2211 has been reported to inhibit the expression of IL-17A and cell viability in lung cancer (4) and suppress inflammation in a collagen-induced arthritis mouse model (45). This evidence concerns the gene RORC and lung carcinoma.